United Therapeutics
UTHR
UTHR
690 hedge funds and large institutions have $17.1B invested in United Therapeutics in 2025 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 207 increasing their positions, 277 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.7% less ownership
Funds ownership: 97.28% → 90.58% (-6.7%)
25% less repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 277
51% less call options, than puts
Call options by funds: $622M | Put options by funds: $1.27B
Holders
690
Holding in Top 10
17
Calls
$622M
Puts
$1.27B
Top Buyers
| 1 | +$318M | |
| 2 | +$213M | |
| 3 | +$81.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$78.2M |
| 5 |
Millennium Management
New York
|
+$76.1M |
Top Sellers
| 1 | -$161M | |
| 2 | -$146M | |
| 3 | -$120M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$120M |
| 5 |
Amundi
Paris,
France
|
-$106M |
